The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Users' Guides to the Medical Literature: XIX. Applying Clinical Trial Results A. How to Use an Article Measuring the Effect of an Intervention on Surrogate End Points
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Self-citationBlood pressure, stroke, and coronary heart disease
Collins, R., Peto, R., MacMahon, S., Godwin, J., Qizilbash, N., Collins, R., MacMahon, S., Hebert, P., Eberlein, K. A., Taylor, J. O., et al. (1990) · The Lancet · doi:10.1016/0140-6736(90)90944-z · Cited by 4,491
Black, D. M., Cummings, S. R., Karpf, D. B., Cauley, J. A., Thompson, D. E., Nevitt, M. C., Bauer, D. C., Genant, H. K., Haskell, W. L., Marcus, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)07088-2 · Cited by 3,846
Marshall, D., Johnell, O., & Wedel, H. (1996) · BMJ · doi:10.1136/bmj.312.7041.1254 · Cited by 3,709
Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
Hepherd, J. A. S., Obbe, S. T. M. C., Ord, I. A. F., Sles, C. H. G. I., Orimer, A. R. O. L., Acfarlane, P. E. W. M., Illop, J. A. H. M. C. K., Ackard, C. H. J. P., & Roup, S. T. G. (1995) · Cited by 3,453
Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103213241201 · Cited by 3,253
Staessen, J. A., Fagard, R., Thijs, L., Celis, H., Arabidze, G. G., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Dollery, C. T., Fletcher, A. E., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(97)05381-6 · Cited by 2,989
Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma
Mellors, J. W., Rinaldo, C. R., Gupta, P., White, R. M., Todd, J. A., & Kingsley, L. A. (1996) · Science · doi:10.1126/science.272.5265.1167 · Cited by 2,660
Hammer, S. M., Squires, K. E., Hughes, M. D., Grimes, J. M., Demeter, L. M., Currier, J. S., Eron, J. J., Feinberg, J. E., Balfour, H. H., Deyton, L. R., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371101 · Cited by 2,640
Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,288
Dawson-Hughes, B., Harris, S. S., Krall, E. A., & Dallal, G. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371003 · Cited by 2,277
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
Packer, M., Carver, J. R., Rodeheffer, R. J., Ivanhoe, R. J., DiBianco, R., Zeldis, S. M., Hendrix, G. H., Bommer, W. J., Elkayam, U., Kukin, M. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252103 · Cited by 2,225
Surrogate endpoints in clinical trials: Definition and operational criteria
Prentice, R. L. (1989) · Statistics in Medicine · doi:10.1002/sim.4780080407 · Cited by 2,057
Cummings, S. R., Eckert, S., Krueger, K. A., Grady, D., Powles, T. J., Cauley, J. A., Norton, L., Nickelsen, T., Bjarnason, N. H., Morrow, M., et al. (1999) · JAMA · doi:10.1001/jama.281.23.2189 · Cited by 1,872
Garg, R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520420066040 · Cited by 1,771
Mahler, D. A., Weinberg, D. H., Wells, C. K., & Feinstein, A. R. (1984) · Chest · doi:10.1378/chest.85.6.751 · Cited by 1,292
Bigger, J. T., Fleiss, J. L., Kleiger, R., Miller, J. P., & Rolnitzky, L. M. (1984) · Circulation · doi:10.1161/01.cir.69.2.250 · Cited by 1,286
Law, M. R., Wald, N. J., & Thompson, S. G. (1994) · BMJ · doi:10.1136/bmj.308.6925.367 · Cited by 1,210
Estacio, R. O., Jeffers, B. W., Hiatt, W. R., Biggerstaff, S. L., Gifford, N., & Schrier, R. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803053381003 · Cited by 1,166
Hammer, S. M., Katzenstein, D. A., Hughes, M. D., Gundacker, H., Schooley, R. T., Haubrich, R. H., Henry, W. K., Lederman, M. M., Phair, J. P., Niu, M., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610103351501 · Cited by 1,091
Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with Osteoporosis
Riggs, B. L., Hodgson, S. F., O'Fallon, W. M., Chao, E. Y. S., Wahner, H. W., Muhs, J. M., Cedel, S. L., & Melon, L. J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003223221203 · Cited by 1,088
Jones, P., Kafonek, S., Laurora, I., & Hunninghake, D. (1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00965-x · Cited by 1,067
Muldoon, M. F., Manuck, S. B., & Matthews, K. A. (1990) · BMJ · doi:10.1136/bmj.301.6747.309 · Cited by 960
Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
Watts, N. B., Harris, S. T., Genant, H. K., Wasnich, R. D., Miller, P. D., Jackson, R. D., Licata, A. A., Ross, P., Woodson, G. C., Yanover, M. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007123230201 · Cited by 949
Guyatt, G. H. (1993) · JAMA · doi:10.1001/jama.1993.03510210084032 · Cited by 944
Self-citationStorm, T., Thamsborg, G., Steiniche, T., Genant, H. K., & Sorensen, O. H. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005033221803 · Cited by 935
Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion
Mellors, J. W., Kingsley, L. A., Rinaldo, C. R., Todd, J. A., Hoo, B. S., Kokka, R. P., & Gupta, P. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-8-199504150-00003 · Cited by 917
Psaty, B. M. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540330061036 · Cited by 875
Tatti, P., Pahor, M., Byington, R. P., Mauro, P. D., Guarisco, R., Strollo, G., & Strollo, F. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.597 · Cited by 850
Montaner, J. S. G., Reiss, P., Cooper, D., Vella, S., Harris, M., Conway, B., Wainberg, M. A., Smith, D., Robinson, P., Hall, D., et al. (1998) · JAMA · doi:10.1001/jama.279.12.930 · Cited by 756
Self-citationCaliff, R. M., Adams, K. F., McKenna, W. J., Gheorghiade, M., Uretsky, B. F., McNulty, S. E., Darius, H., Schulman, K., Zannad, F., Handberg-Thurmond, E., et al. (1997) · American Heart Journal · doi:10.1016/s0002-8703(97)70105-4 · Cited by 665
Oxman, A. D. (1993) · JAMA · doi:10.1001/jama.270.17.2093 · Cited by 655
Verschuren, W. M. M. (1995) · JAMA · doi:10.1001/jama.1995.03530020049031 · Cited by 573
DiBianco, R., Shabetai, R., Kostuk, W., Moran, J., Schlant, R. C., & Wright, R. (1989) · New England Journal of Medicine · doi:10.1056/nejm198903163201101 · Cited by 550
Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease
Cameron, D. W., Heath-Chiozzi, M., Danner, S., Cohen, C., Kravcik, S., Maurath, C., Sun, E., Henry, D., Rode, R., Potthoff, A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(97)04161-5 · Cited by 536
Darbyshire, J. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05387-1 · Cited by 509
Katzenstein, D. A., Hammer, S. M., Hughes, M. D., Gundacker, H., Jackson, J. B., Fiscus, S., Rasheed, S., Elbeik, T., Reichman, R., Japour, A., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610103351502 · Cited by 477
How should we measure function in patients with chronic heart and lung disease?
Guyatt, G. H., Thompson, P. J., Berman, L. B., Sullivan, M. J., Townsend, M., Jones, N. L., & Pugsley, S. O. (1985) · Journal of Chronic Diseases · doi:10.1016/0021-9681(85)90035-9 · Cited by 432
Self-citationBakker-Arkema, R. G. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03530260042029 · Cited by 407
Borhani, N. O. (1996) · JAMA · doi:10.1001/jama.1996.03540100029024 · Cited by 302
Prevention of Nonvertebral Fractures by Alendronate: A Meta-analysis
Karpf, D. B. (1997) · JAMA · doi:10.1001/jama.1997.03540380073035 · Cited by 281
Dans, A. L., Dans, L. F., Guyatt, G. H., Richardson, S., & for the Evidence-Based Medicine Working Group (1998) · JAMA · doi:10.1001/jama.279.7.545 · Cited by 257
Self-citationRandomised study of effect of ibopamine on survival in patients with advanced severe heart failure
Hampton, Jr., van Veldhuisen, D., Kleber, F., Cowley, A., Ardia, A., Block, P., Cortina, A., Cserhalmi, L., Follath, F., Jensen, G., et al. (1997) · The Lancet · doi:10.1016/s0140-6736(96)10488-8 · Cited by 256
PREVENTION OF CORONARY HEART DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
SHEPHERD, J., COBBE, S. M., FORD, I., ISLES, C. G., LORIMER, A. R., MACFARLANE, P. W., MCKILLOP, J. H., & PACKARD, C. J. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.029 · Cited by 245
Drexler, H., Banhardt, U., Meinertz, T., Wollschläger, H., Lehmann, M., & Just, H. (1989) · Circulation · doi:10.1161/01.cir.79.3.491 · Cited by 239
Cooper, D. A., Gatell, J. M., Kroon, S., Clumeck, N., Millard, J., Goebel, F.-D., Bruun, J. N., Stingl, G., Melville, R. L., Gonzalez-Lahoz, J., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199307293290501 · Cited by 216
McAlister, F. A., Laupacis, A., Wells, G. A., Sackett, D. L., & for the Evidence-Based Medicine Working Group (1999) · JAMA · doi:10.1001/jama.282.14.1371 · Cited by 177
Self-citationSaravolatz, L. D., Winslow, D. L., Collins, G., Hodges, J. S., Pettinelli, C., Stein, D. S., Markowitz, N., Reves, R., Loveless, M. O., Crane, L., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610103351503 · Cited by 175
Meunier, P. J., Sebert, J.-L., Reginster, J.-Y., Briancon, D., Appelboom, T., Netter, P., Loeb, G., Rouillon, A., Barry, S., Evreux, J.-C., et al. (1998) · Osteoporosis International · doi:10.1007/s001980050041 · Cited by 168
Delmas, P. D., Bjarnason, N. H., Mitlak, B., Ravoux, A.-C., Shah, A. S., Huster, W. J., Draper, M. W., & Christiansen, C. (1998) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199805000-00020 · Cited by 148
Surrogate markers in aids and cancer trials
Fleming, T. R. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131318 · Cited by 115
Massie, B. M., Berk, M. R., Brozena, S. C., Elkayam, U., Plehn, J. F., Kukin, M. L., Packer, M., Murphy, B. E., Neuberg, G. W., & Steingart, R. M. (1993) · Circulation · doi:10.1161/01.cir.88.2.492 · Cited by 102
Jones, I. R., Swai, A. B. M., Taylor, R., Miller, M. A., Laker, M. F., & Alberti, K. G. M. M. (1990) · Diabetes Care · doi:10.2337/diacare.13.8.855 · Cited by 90
Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure
Riegger, G. A. J. (1991) · European Heart Journal · doi:10.1093/eurheartj/12.6.705 · Cited by 79
Safety and efficacy of epoprostenol in patients with severe congestive heart failure
Sueta, C. A., Gheorghiade, M., Adams, K. F., Bourge, R. C., Murali, S., Uretsky, B. F., PRITZKER, M. R., McGoon, M. D., Butman, S. M., Grossman, S. H., et al. (1995) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)80381-6 · Cited by 71
Basic statistics for clinicians: 4. Correlation and regression.
Guyatt, G. H., Walter, S. D., Shannon, H. S., Cook, D., Jaeschke, R., & Heddle, N. M. (1995) · Europe PMC (PubMed Central) · Cited by 57
Self-citationShort-Term and Long-Term Fracture Prediction by Bone Mass Measurements: A Prospective Study
Huang, C. D., Ross, P. D., & Wasnich, R. D. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.1.107 · Cited by 55
Heinonen, T., Stein, E., Weiss, S., Mckenney, J., Davidson, M., Shurzinske, L., & Black, D. (1996) · Clinical Therapeutics · doi:10.1016/s0149-2918(96)80045-2 · Cited by 50
Antiarrhythmic Therapies for the Prevention of Sudden Cardiac Death
McAlister, F. A., & Teo, K. K. (1997) · Drugs · doi:10.2165/00003495-199754020-00003 · Cited by 45
Self-citationHypertension and Outcomes Research from Clinical Trials to Clinical Epidemiology
Psaty, B. M., Siscovick, D. S., Weiss, N. S., Koepsell, T. D., Rosendaal, F. R., Lin, D., Heckbert, S. R., Wagner, E. H., & Furberg, C. D. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(96)00015-5 · Cited by 30
Comparison of lisinopril versus placebo for congestive heart failure
Lewis, G. R. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90411-6 · Cited by 27
S-9. Raloxifene Reduces the Risk of Incident Vertebral Fractures
Ettinger, B. B., Black, D. M., Cummings, S. R., et al. (1998) · Menopause The Journal of The North American Menopause Society · doi:10.1097/00042192-199805040-00047 · Cited by 24
Can drug effects on mortality in heart failure be predicted by any surrogate measure?
YEE, K. M., & Struthers, A. D. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015193 · Cited by 24
Winocour, P., Durrington, P., Bhatagnar, D., Ishola, M., Mackness, M., Arrol, S., & Anderson, D. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90202-r · Cited by 14
Cited by
Current methods of the U.S. Preventive Services Task Force
Harris, R. P., Helfand, M., Woolf, S. H., Lohr, K. N., Mulrow, C. D., Teutsch, S. M., & Atkins, D. (2001) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(01)00261-6 · Cited by 1,731
Harnessing neuroplasticity for clinical applications
Cramer, S. C., Sur, M., Dobkin, B. H., O'Brien, C., Sanger, T. D., Trojanowski, J. Q., Rumsey, J. M., Hicks, R., Cameron, J., Chen, D., et al. (2011) · Brain · doi:10.1093/brain/awr039 · Cited by 1,259
(2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.06.008 · Cited by 727
Zhou, H., Romano, P., & White, R. (2003) · Thrombosis and Haemostasis · doi:10.1160/th03-03-0152 · Cited by 598
Kramer, D. G., Trikalinos, T. A., Kent, D. M., Antonopoulos, G. V., Konstam, M. A., & Udelson, J. E. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.011 · Cited by 492
Metadata
- Authors
- Bucher, H. C., Guyatt, G. H., Cook, D. J., Holbrook, A., McAlister, F. A., & for the Evidence-Based Medicine Working Group
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 1999-08-25
- Volume
- 282
- Issue
- 8
- Pages
- 771
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2126426045
- Cited by
- 361
- References
- 69
- FWCI
- 75.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.